Autoimmune recognition of β-cell antigens leads to decreased β-cell mass and the subsequent decline of insulin-mediated regulation of glucose levels in the blood eventually results in chronic hyperglycemia and T1D. This evidence concerns the gene INS and type 1 diabetes mellitus.